Which pair of medications is a therapeutic duplication?
Celexa and Paxil are a therapeutic duplication.
Both Celexa (citalopram) and Paxil (paroxetine) are selective serotonin reuptake inhibitors (SSRIs) used to treat depression and anxiety disorders. Prescribing both medications simultaneously can lead to an increased risk of side effects without additional therapeutic benefit, thus constituting a therapeutic duplication.
As both medications belong to the SSRI class, they function similarly in increasing serotonin levels in the brain. Using them together does not provide any added efficacy for treating depression or anxiety and can lead to an increased risk of side effects, including serotonin syndrome, making this combination a classic example of therapeutic duplication.
Celexa is an SSRI, while Toprol XL (metoprolol) is a beta-blocker used primarily for heart conditions. These medications serve different therapeutic purposes and do not overlap in their pharmacological action, which means there is no therapeutic duplication between them; they can be safely prescribed together if clinically warranted.
Ditropan XL (oxybutynin) is an anticholinergic agent used to treat overactive bladder, while Paxil is an SSRI. These medications target entirely different conditions and mechanisms of action, so their use together does not constitute therapeutic duplication, as they serve distinct therapeutic roles.
Ditropan XL and Toprol XL also represent different classes of medications—an anticholinergic and a beta-blocker, respectively. Since they are prescribed for different medical issues and do not have overlapping therapeutic effects, there is no therapeutic duplication in their concurrent use.
Therapeutic duplication occurs when two medications with similar effects are prescribed together, leading to potential risks without added benefit. In this case, the pairing of Celexa and Paxil exemplifies this issue due to their shared classification as SSRIs. In contrast, the other options consist of medications that do not duplicate therapeutic effects, highlighting the importance of careful medication management to avoid unnecessary complications.
Related Questions
View allAccording to federal law, the monthly sales limit for pseudoephedrine-...
Which of the following is the brand name for dapagliflozin?
According to USP Chapter 795, the labeling of a compounded nonsterile...
A root-cause analysis (RCA) should be completed in the event of a:
According to federal law, a new NDC number must be assigned after a su...
Related Quizzes
View allPharmacy Technician Certification Exam PTCE
PTCE Pharmacy Technician Certification Exam
PTCE Blue Print for Pharmacy Technician Certification
Pharmacy Technician Certification Exam PTCE Practice Questions
Master The Pharmacy Technician Certification Exam PTCE
Pharmacy Technician Certification Exam Answers
PTCE With Online Test Pharmacy Technician Certification Exam
Certified Pharmacy Technician Certification
Pharmacy Technician Certification Board Practice Exam
Pharmacy Technician Certification Exam Practice Test
- ✓ 500+ Practice Questions
- ✓ Detailed Explanations
- ✓ Progress Analytics
- ✓ Exam Simulations